SEONGNAM, South Korea, July 16, 2025 /PRNewswire/ -- In a strong endorsement of its cutting-edge drug delivery technology, SN BioScience announced that its anticancer candidate SNB-101 has been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback